Realfiction (REALFI) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jun, 2025Executive summary
Q3-2024 revenue surged 287% year-over-year to SEK 9.8 million, driven by a SEK 7.4 million DPT proof-of-concept sale.
Gross profit margin rose to 82.1% from 64.9% in Q3-2023, reflecting high-margin DPT sales.
Net result after financial items improved to SEK -0.34 million from SEK -1.53 million year-over-year.
Mixed reality display business remained stable, with a growing order backlog for Q4-2024.
Strategic focus on commercializing Directional Pixel Technology (DPT) and expanding production capabilities.
Financial highlights
Q3-2024 revenue: SEK 9.8 million (Q3-2023: SEK 2.5 million); Q1-Q3 2024: SEK 14.0 million (Q1-Q3 2023: SEK 7.1 million).
Gross profit: SEK 8.1 million in Q3-2024 (Q3-2023: SEK 1.6 million); margin 82.1%.
Result after financial items: SEK -0.34 million in Q3-2024 (Q3-2023: SEK -1.53 million); Q1-Q3 2024: SEK -17.0 million.
Cash flow from operating activities: SEK -4.1 million in Q3-2024 (Q3-2023: SEK -0.24 million).
Equity at period end: SEK 51.7 million (Q3-2023: SEK 70.0 million).
Outlook and guidance
Payment for the SEK 7.4 million DPT agreement expected in Q4-2024, extending liquidity through H1-2025.
Focus on signing additional DPT licensing agreements and expanding the team in Taiwan.
Order backlog for mixed reality displays at SEK 1.4 million entering Q4-2024, up from SEK 0.2 million year-over-year.
Latest events from Realfiction
- Sharp revenue drop in Q3 as DPT sales paused; capital raised to support DPT commercialization.REALFI
Q3 202527 Nov 2025 - SEK 50 million rights issue supports commercialization of advanced glasses-free 3D display tech.REALFI
Status Update23 Nov 2025 - DPT commercialization advances with improved margins and new funding, despite lower revenue.REALFI
Q2 202528 Jul 2025 - Q2-2024 saw strong revenue growth and DPT licensing talks nearing a breakthrough.REALFI
Q2 202413 Jun 2025 - DPT commercialization accelerates with new funding and industry milestones despite lower revenue.REALFI
Q1 20256 Jun 2025 - Revenue surged and DPT commercialization advanced with a pivotal license agreement.REALFI
Q4 20245 Jun 2025